Search

everythinglearnresearchcommunity

for

Search:↓

Tet2 and Tet3 enzymes are essential for controlling hair growth by affecting DNA demethylation and gene expression in mice.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The compounds tested could potentially treat hair loss and alopecia.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

The B2 genes are crucial for hair growth in rats.

Variant G of the KRTAP20-1 gene improves wool curliness in Chinese Tan sheep.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Mice without certain skin enzymes have faster hair growth and bigger eye glands.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

Pertussis toxin may contribute to hair loss in alopecia areata.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

BIK1 gene helps plants resist some pathogens but makes them more vulnerable to others.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A specific gene change is linked to severe hair loss.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Sesamin may help treat hair loss by affecting specific cell pathways.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.